Ziv Ben‐Ari

6.0k total citations
57 papers, 1.2k citations indexed

About

Ziv Ben‐Ari is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ziv Ben‐Ari has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 29 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Ziv Ben‐Ari's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (20 papers) and Hepatitis B Virus Studies (12 papers). Ziv Ben‐Ari is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (20 papers) and Hepatitis B Virus Studies (12 papers). Ziv Ben‐Ari collaborates with scholars based in Israel, United Kingdom and United States. Ziv Ben‐Ari's co-authors include Amar P. Dhillon, Andrew K. Burroughs, Sheila Sherlock, Ran Tur‐Kaspa, Michal Safran, Maya Sultan, Eytan Mor, David Patch, Steven Bates and John Pasi and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Ziv Ben‐Ari

56 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ziv Ben‐Ari

Since Specialization

Citations

This map shows the geographic impact of Ziv Ben‐Ari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziv Ben‐Ari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziv Ben‐Ari more than expected).

Fields of papers citing papers by Ziv Ben‐Ari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziv Ben‐Ari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziv Ben‐Ari. The network helps show where Ziv Ben‐Ari may publish in the future.

Co-authorship network of co-authors of Ziv Ben‐Ari

This figure shows the co-authorship network connecting the top 25 collaborators of Ziv Ben‐Ari. A scholar is included among the top collaborators of Ziv Ben‐Ari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziv Ben‐Ari. Ziv Ben‐Ari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients 2023 ·Viruses ·Yana Davidov, Victoria Indenbaum, Michal Mandelboim, Keren Asraf, Tal Gonen, (unknown), Oranit Cohen‐Ezra, Mariya Likhter, Ital Nemet, Limor Kliker, Orna Mor, Ram Doolman, Carmit Cohen, Arnon Afek, Yitshak Kreiss, Gili Regev‐Yochay, Yaniv Lustig, Ziv Ben‐Ari	1
2	Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial 2020 ·BMC Infectious Diseases ·(unknown), Inbal Houri, Ziv Ben‐Ari, Amir Shlomai, Ella Veitsman, Oranit Cohen‐Ezra, Assaf Issachar, Orna Mor, Yael Gozlan, Rafael Bruck, Yoram Menachem, Shira Zelber‐Sagi, Helena Katchman, Oren Shibolet	5
3	Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009–2017 2019 ·Epidemiology and Infection ·Ravit Bassal, Marina Wax, Rachel Shirazi, Tamy Shohat, Dani Cohen, (unknown), Saif Abu‐Mouch, Yasmin Abu‐Ghanem, Ella Mendelson, Ziv Ben‐Ari, Orna Mor	12
4	Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis 2018 ·Clinical Gastroenterology and Hepatology ·Joseph K. Lim, (unknown), Mitchell L. Shiffman, Anna S. Lok, Stefan Zeuzem, Norah A. Terrault, James Park, Charles Landis, Mohamed A. Hassan, Joel E. Gallant, Alexander Kuo, Paul J. Pockros, Monika Vainorius, Lucy Akushevich, (unknown), Michael Fried, David R. Nelson, Ziv Ben‐Ari	13
5	Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production 2018 ·Molecular Medicine ·Neta Gotlieb, (unknown), (unknown), Maya Sultan, Michal Safran, Ziv Ben‐Ari	30
6	Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation 2017 ·PLoS ONE ·(unknown), Maya Sultan, (unknown), Michal Safran, Ziv Ben‐Ari	71
7	Endovascular Diagnosis and Intervention in Patients with Isolated Hyperammonemia, with or without Ascites, after Liver Transplantation 2008 ·Journal of Vascular and Interventional Radiology ·Alexander Belenky, (unknown), (unknown), Gil N. Bachar, (unknown), (unknown), Ziv Ben‐Ari, Ran Tur‐Kaspa, Eli Atar	1
8	Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post‐transplant hepatitis C infection 2007 ·Clinical Transplantation ·Hemda Schmilovitz‐Weiss, Michal Cohen, Orit Pappo, Jaqueline Sulkes, Marius Braun, Ran Tur‐Kaspa, Ziv Ben‐Ari	11
9	Neoral dose monitoring using 2‐hour cyclosporine post‐dose levels in stable children with liver transplants: Improvement in renal function 2003 ·Pediatric Transplantation ·Rivka Shapiro, (unknown), Eytan Mor, (unknown), Moshe Nussinovitch, Gabriel Dinari, Ziv Ben‐Ari	3
10	Excellent Outcome of Lamivudine Treatment in Patients With Chronic Renal Failure and Hepatitis B Virus Infection 2003 ·Journal of Clinical Gastroenterology ·Hemda Schmilovitz‐Weiss, Ehud Melzer, Ran Tur‐Kaspa, Ziv Ben‐Ari	23
11	PRIMARY HYPEROXALURIA TYPE 1: IMPROVED OUTCOME WITH TIMELY LIVER TRANSPLANTATION: A SINGLE-CENTER REPORT OF 36 CHILDREN 2001 ·Transplantation ·Rivka Shapiro, (unknown), (unknown), (unknown), Ziv Ben‐Ari, N Bar-Nathan, (unknown), Gabriel Dinari, Eytan Mor	60
12	Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation 2001 ·Liver Transplantation ·Ziv Ben‐Ari, Eytan Mor, (unknown), Ran Tur‐Kaspa	33
13	DEFIBROTIDE FOR THE TREATMENT OF VENO-OCCLUSIVE DISEASE AFTER LIVER TRANSPLANTATION 2001 ·Transplantation ·Eytan Mor, Orit Pappo, N Bar-Nathan, E Shaharabani, (unknown), Ran Tur‐Kaspa, Ziv Ben‐Ari	24
14	Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis 2000 ·The American Journal of Gastroenterology ·Ziv Ben‐Ari, (unknown), Yehudit Monselise, (unknown), (unknown), Orit Pappo, (unknown), Ran Tur‐Kaspa	26
15	EXTENSION OF TRANSPLANTATION FREE TIME BY LAMIVUDINE IN PATIENTS WITH HEPATITIS B-INDUCED DECOMPENSATED CIRRHOSIS 2000 ·Transplantation ·Yona Kitay‐Cohen, Ziv Ben‐Ari, Ran Tur‐Kaspa, (unknown), Michael Lishner	20
16	Posttransplantation lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome 1999 ·Liver Transplantation and Surgery ·Ziv Ben‐Ari, P L Amlot, (unknown), Ran Tur‐Kaspa, Keith Rolles, Andrew K. Burroughs	34
17	A predictive model for failure to control bleeding during acute variceal haemorrhage 1999 ·Journal of Hepatology ·Ziv Ben‐Ari, (unknown), P. Aiden McCormick, S. Goya Wannamethee, Andrew K. Burroughs	93
18	Eosinophils in acute cellular rejection in liver allografts 1998 ·Liver Transplantation and Surgery ·Aabha Nagral, Ziv Ben‐Ari, Amar P. Dhillon, Andrew K. Burroughs	37
19	Infection rates with and without T-tube splintage of common bile duct anastomosis in liver transplantation 1998 ·Transplant International ·Ziv Ben‐Ari, (unknown), Brian R Davidson, Keith Rolles, A K Burroughs	30
20	Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography 1997 ·Journal of Hepatology ·Ziv Ben‐Ari, (unknown), David Patch, Steven Bates, (unknown), John Pasi, Andrew K. Burroughs	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact